A catalytic asymmetric synthesis of AS-3201 via catalytic asymmetric amination with a novel lanthanum−amide complex is described. The amination reaction proceeded efficiently with as little as 1 mol % of catalyst loading, allowing for an efficient access to the key intermediate for the synthesis of AS-3201, a potent aldose reductase inhibitor.
No takes yet. Share an insight, caveat, or question.
Mashiko et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: